The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These novel therapies represent a significant https://sahildwtz049878.ktwiki.com/1929453/glp_3_receptor_agonists_retatrutide_trizepatide